Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells. - Wikidata - awgldk - TriplyDB

Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells.

Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells.

http://www.wikidata.org/entity/Q38536402

about

Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns Neural Conversion and Patterning of Human Pluripotent Stem Cells: A Developmental Perspective Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion Expression of Neurogenin 1 in mouse embryonic stem cells directs the differentiation of neuronal precursors and identifies unique patterns of down-stream gene expression Screening of bioactive peptides using an embryonic stem cell-based neurodifferentiation assay A bi-modal function of Wnt signalling directs an FGF activity gradient to spatially regulate neuronal differentiation in the midbrain Probing embryonic stem cell autocrine and paracrine signaling using microfluidics Multi-level characterization of balanced inhibitory-excitatory cortical neuron network derived from human pluripotent stem cells.Integration of signals along orthogonal axes of the vertebrate neural tube controls progenitor competence and increases cell diversity The doublesex-related Dmrta2 safeguards neural progenitor maintenance involving transcriptional regulation of Hes1 Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells.MicroRNA-based promotion of human neuronal differentiation and subtype specification.Specification of midbrain dopamine neurons from primate pluripotent stem cells.Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease Glycogen synthase kinase 3β and activin/nodal inhibition in human embryonic stem cells induces a pre-neuroepithelial state that is required for specification to a floor plate cell lineage.The epigenome of AML stem and progenitor cells Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy.Cortical interneurons from human pluripotent stem cells: prospects for neurological and psychiatric disease.BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells.Clonal isolation of an intermediate pluripotent stem cell state.Lmx1a allows context-specific isolation of progenitors of GABAergic or dopaminergic neurons during neural differentiation of embryonic stem cells.Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.FolR1: a novel cell surface marker for isolating midbrain dopamine neural progenitors and nascent dopamine neurons.Genome-wide characterisation of Foxa1 binding sites reveals several mechanisms for regulating neuronal differentiation in midbrain dopamine cells Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.Dissecting the role of Wnt signaling and its interactions with FGF signaling during midbrain neurogenesis.Parkinson's Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything?Hierarchical folding and reorganization of chromosomes are linked to transcriptional changes in cellular differentiation.Behavioural recovery on simple and complex tasks by means of cell replacement therapy in unilateral 6-hydroxydopamine-lesioned mice.RNA polymerase II primes Polycomb-repressed developmental genes throughout terminal neuronal differentiation.Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons.Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation.Acetyl-11-keto-β-boswellic acid extracted from Boswellia serrata promotes Schwann cell proliferation and sciatic nerve function recovery.

P2860

Q26745513-81641C3E-AED5-4C6D-99D4-17D35BB6334B Q26749087-6ED2E1D9-CBD2-45D2-9991-699D73595E70 Q27004350-2DD51C7D-7803-41B5-AF9F-A91B1AD545CC Q28506854-9614203F-053A-4F24-935D-289B42807FB0 Q28657872-8061BA51-17A4-4169-935F-735AC7FD8C76 Q30559743-1E6F9CAF-C131-4449-AECB-A5D49AE52791 Q33647797-9B5FCAAC-03B4-43C2-B0DA-8996B11CD782 Q33769096-A0B3D24D-7684-48DF-BB6D-2BB012551E44 Q33904021-DC4D5F84-3AFE-43E3-B65B-787ED1E031F3 Q33913672-CEEBE8EA-9DEF-49FA-8BDA-37BE11D62A96 Q34571086-E25E8848-485F-4201-8055-A221C3B51944 Q34634519-7EAFF20D-E5A7-4A13-A7CF-CF9CE9FAA5A2 Q36117009-9FCF0DCB-D0BB-4B10-BA06-2C5218BFE534 Q36250893-4E904A71-33C5-4505-81C9-A0AE86FEEBC1 Q36498676-0D1BAD78-A23D-4DDA-AA79-95AE4D2C6585 Q36548067-0DF9878B-66A5-4F1D-B963-2E414A37BAAB Q38044388-BD10AA75-6261-46E2-BC4E-08F83C8403C5 Q38089608-B63781E6-3B84-4FFD-82B6-7F4D743F8D53 Q38710630-0D8A86F4-5BD7-45DF-8F5D-F9C1B02FD851 Q39206425-654C92CB-7953-4278-B04A-DF054C68802D Q39365728-12C78EFC-847C-4E3E-93B4-D1542F623B3D Q40047888-86B061F1-3393-471E-B155-D47905FFDBD4 Q40991099-1D006B66-97D1-46C7-AED6-F03F93925B66 Q41169511-04BB1FB4-7796-4FF3-9040-D7D6E72D4695 Q41769703-FFC22C9D-0D42-40EF-A639-446B6F23DE26 Q42380972-C247CF24-1377-421F-A555-74915AE013B5 Q42562656-DFD7B9E0-B073-4415-8D29-273485CAAED4 Q43101354-7465CBE6-3914-497D-9018-E2EEAD9EF317 Q45363661-D32A0914-040D-49AA-8F5E-D943A260C909 Q46594026-FF6DA490-83DA-4915-8932-BB7A35869C70 Q47702394-05ED4A06-9F37-4E4E-835B-A24A91446EF9 Q52589683-F68F3105-E72A-48FC-A263-A3F62DB64683 Q52727302-74BDB705-066F-42BF-B232-02F82F41BBCA Q54117290-05FD2F3B-5B75-4BAD-BA40-A2F4BE362CA0

P2860

Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells.

http://www.wikidata.org/entity/Q38536402

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Temporally controlled modulati ...... human pluripotent stem cells.

@en

type

label

Temporally controlled modulati ...... human pluripotent stem cells.

@en

prefLabel

Temporally controlled modulati ...... human pluripotent stem cells.

@en

P1433

Q38536402-30E73FB1-D6C8-43E3-B3C5-2FF2664459B8

P1476

Q38536402-D41A25CA-C7BD-4BE7-80B1-F7065B6FC3D1

P2093

Q38536402-198C1C32-8B6B-4B96-9CAA-B5502A560A51

Q38536402-281580CF-C915-4B21-9139-20162A4A4941

Q38536402-373CAD36-7B39-4D7E-B48F-0D49D225DA6B

Q38536402-747BF3A5-0041-48AB-906E-F22012E6DD1D

Q38536402-BE4EAF76-1351-4846-A67F-24914608FA3D

Q38536402-C66FB54D-E004-4BA5-8B55-01684CAA7BB9

Q38536402-C8EF94D1-68BD-4E8F-B2ED-ABF392F109CA

P2860

Q38536402-0092F5DC-1451-4187-A5E4-978F230240D4

Q38536402-0376DE25-F586-4AE2-ABE5-8011F6921FCB

Q38536402-05D1007E-2C3A-47E8-B268-4A28AEC6EB84

Q38536402-0ACD3214-5891-4545-B0D7-16F4EF5F438F

Q38536402-10548280-E459-41D7-9C6E-943F2ED4C769

Q38536402-112FF9B9-4659-4E9B-85DC-FE83CACCDB31

Q38536402-1232E0C9-8F98-464C-8337-C7281D9C8FCC

Q38536402-12D8A4E0-2C78-49A0-B669-CEBE0356E3F1

Q38536402-158E1BBB-2295-4099-8CC9-4FC05F96A7AE

Q38536402-251607B2-8963-4D2F-B0BD-211CE5CA5495

P304

Q38536402-976FB0E1-248D-40EB-BF5D-84211A151A66

P31

Q38536402-F04BCC28-3B27-4B3F-89D1-4F6EE3FC9426

P356

Q38536402-9FDA85C3-3DEC-4484-BFAE-A5F8C2B89539

P407

Q38536402-8B07633C-5D2E-42E8-9C9F-4E7E47DB54E5

P433

Q38536402-DD7B5073-037C-4CF6-8A44-D960E4463A2A

P478

Q38536402-A77F6ABF-BB43-4BCA-A464-1DEF27B610F9

P50

Q38536402-27857521-CA0C-450F-83C0-9EA72A387345

Q38536402-C5555935-C2AB-4DE3-A596-3F7991F23A37

P577

Q38536402-548B160B-5C2C-446E-894B-BA2833B0443E

P5875

Q38536402-2E2786B8-1BF7-43A4-B9AF-E82340FF330A

P698

Q38536402-7B02B931-9516-4716-960B-C4BDE912C23F

P921

Q38536402-0DB2F8FD-99D0-471F-A6B9-6D271CB99401

P932

Q38536402-269B0AA1-ACA6-40E6-9324-C1E3228E2933

P356

P1433

P1476

Temporally controlled modulati ...... human pluripotent stem cells.

@en

P2093

Diana Pritzsche

http://www.w3.org/2001/XMLSchema#string

I-Cheng Chen

http://www.w3.org/2001/XMLSchema#string

Ines Jaeger

http://www.w3.org/2001/XMLSchema#string

Jessica R Risner-Janiczek

http://www.w3.org/2001/XMLSchema#string

Judit Kuechler

http://www.w3.org/2001/XMLSchema#string

Meng Li

http://www.w3.org/2001/XMLSchema#string

Thulasi Naveenan

http://www.w3.org/2001/XMLSchema#string

P2860

The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age

Wnt1-lmx1a forms a novel autoregulatory loop and controls midbrain dopaminergic differentiation synergistically with the SHH-FoxA2 pathway

Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis

Gata2 is a tissue-specific post-mitotic selector gene for midbrain GABAergic neurons

FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate

Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3

Doublesex and mab-3-related transcription factor 5 promotes midbrain dopaminergic identity in pluripotent stem cells by enforcing a ventral-medial progenitor fate

Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development

A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo

Fate of midbrain dopaminergic neurons controlled by the engrailed genes

P304

4363-4374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/DEV.066746

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51608486

http://www.w3.org/2001/XMLSchema#string

P698

21880784

http://www.w3.org/2001/XMLSchema#string

P921

P932

3177308

http://www.w3.org/2001/XMLSchema#string